Reuters reports a new analysis of Novo Nordisk's CagriSema data, with women in the trials losing a quarter of their body weight on average.
Recap by typeshit. Full story at Investing.com.
A Facebook share says Danish teams found certain bacterial strains may change how the gut tells the brain it is full. The work so far is in animal models only.
Bikman calls the results remarkable, but he argues that bigger drops make it more important to know how much of the lost weight is fat and how much is muscle.
Bikman points out that weight usually returns once the drug is stopped, which makes the question of lifelong use a real one.
Avi Roy flags a preprint that pooled 10,052 people from five semaglutide trials and used a blood test to estimate heart age. It has not yet been peer reviewed.
Bazaar looks at how the beauty business is reacting to GLP-1 side effects, from 'Ozempic face' to worries about collagen loss and loose skin.
A doctor's explainer for people weighing peptides. Only the title came through, so the specific advice is in the full piece.
Loading…